Circular polarization (CP), Linear Polarization (LP) and Multi-Channel-N (MC-N) are RF transmit technologies at 3T. The B1+ peak limit is dependent on the RF coil amplifier topology and the transmit scheme. This may lead to significant changes in the induced E field in a patient and affect the MR safety assessment for active implantable medical devices (AIMDs). This abstract shows that even though B1+ peak levels of LP is lower than that of CP or MC-N, the E-field along an implant during LP can exceed CP or MC-N. Therefore, since LP can be achieved within CP or MC-N, it should be considered for AIMD MR safety assessment.
Transmit technologies are defined as:
In this abstract, the focus is 2-port body coils. The designs can be categorized into two fundamental configurations: RF power amplifier with hybrid splitter to construct CP or MC-2(Figure 1(a), (c)), and independent RF power amplifiers to construct MC-2 (Figure 1 (b)). LP may occur at each independent port (shown as red circles in Figure 1) during the pre-scan for any configuration. To compare the maximum B1+ peak level at hardware limit of MR scanners in CP, LP and MC-2 for each configuration in Figure 1, we assume: 1) maximum peak delivered power is applied to one of the RF amplifiers, 2) the hybrid splitters are lossless, 3) there is perfect impedance matching and negligible coil loss.
To construct LP, CP and MC-2, electromagnetic (EM) fields in human models for each port is simulated with Sim4Life1 and then combined to produce each transmit technology. Both ports (denoted as I port and Q port) are simulated separately for Duke model from V3 Virtual Population2 in a 70cm diameter 3T RF body coil at thoracic imaging position. As suggested by Murbach et al3, an amplitude ratio of 0.5, 1, 1.5 and phase difference of 45°, 90°, and 135° for MC-2 RF shimming were used. After EM field combination, the B1+ field in the human body, averaged over isocenter plane, was calculated per IEC 60601-2-334.
For independent RF amplifiers (Figure 1 (b)), the same peak power was delivered to each port at CP, then the maximum B1+ peak level of CP was normalized to 1µT. The LP and MC-2 cases follow the same normalization factor.
For single RF amplifier (Figure 1 (a), (c)), the maximum power for the RF amplifier was delivered for LP, CP and MC-2 cases. The B1+ peak levels were normalized to 1µT for CP scenario. The LP and MC-2 cases are normalized using the same total delivered power.
If the independent RF amplifiers (Figure 1 (b)) are applied, the B1+ peak levels are plotted in Figure 2. To show the impact of B1+ peak level on E field distribution, we choose amplitude 0.5 and phase 45° for MC-2. The E field distributions at isocenter plane and Etan along a typical cardiac pathway for each transmit technology are shown in Figure 3.
If single RF power amplifier with switchable hybrid splitter (Figure 1 (a) and (c)) is used, the B1+ peak levels are plotted in Figure 4. Figure 5 shows the E field distributions at isocenter plane and along a typical cardiac pathway for each transmit technology.
B1+ peak levels from LP can be lower than that of CP and MC-2 in line with previous finding5. However, in the case of the single RF power amplifier, the changes in E field distributions were enough for the Etan along an implant pathway for LP to exceed CP and MC-2.